Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ener Thistle is a multi-ingredient dietary supplement formulated to support hepatic health and detoxification processes. The primary active constituent is silymarin, a standardized extract from milk thistle (*Silybum marianum*) containing a complex of flavonolignans such as silybin. Silymarin functions as a hepatoprotective agent by stabilizing cell membranes, scavenging reactive oxygen species, and increasing intracellular glutathione levels. Furthermore, it stimulates RNA polymerase I in hepatocytes, which enhances ribosomal protein synthesis and facilitates the regeneration of liver tissue. The formulation often includes complementary botanical extracts like dandelion and licorice to promote bile flow and provide additional anti-inflammatory benefits. It is primarily indicated for the maintenance of liver function and as an adjunctive support for chronic liver conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ener Thistle.